Liam Handley, 36, tragically passed away from lung cancer after being misdiagnosed with anxiety. Doctors dismissed his chest ...

The U.S. Food and Drug Administration has approved Galderma's Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older.

This Phase II trial explores CBD for anxiety in breast cancer patients, indicating safety and potential anxiolytic effects ...

Researchers have achieved impressive results in animal studies with a new weight-loss drug that has no GLP-1-style side ...

A recent study by Columbia University has revealed that ACE inhibitors, one of the most commonly prescribed medications for ...

Boosting the endocannabinoid 2-AG in the brain can counteract opioid addiction while preserving their pain relief, a Weill ...

The reversal comes after a state investigation and charges by advocacy groups that proposed policy changes would violate the Affordable Care Act.

A New Jersey pharmaceutical company is recalling more than 230,000 bottles of duloxetine antidepressants after detecting a ...

Mind Medicine Inc., a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health ...

For the first time ever, researchers are administering LSD to patients in a Phase 3 clinical trial. The new study focuses on whether the psychedelic can be used to effectively treat generalized ...

Mind Medicine (MNMD) has released an update.Pick the best stocks and maximize your portfolio:Discover top-rated stocks from highly ranked ...

A monoclonal antibody that targets interleukin (IL)-31 receptor alpha, nemolizumab is specifically indicated for individuals ...